Hoyer D, Neijt H C, Karpf A
Preclinical Research, SANDOZ Ltd, Basel, Switzerland.
J Recept Res. 1989;9(1):65-79. doi: 10.3109/10799898909066045.
[3H]ICS 205-930 labelled 5-HT3 recognition sites in membranes prepared from murine neuroblastoma N1E-115 cells. Binding was rapid, reversible, saturable and stereoselective to an apparently homogeneous population of sites. Kinetic studies revealed that agonists and antagonists produced a monophasic dissociation reaction of [3H]ICS 205-930 from its recognition sites. The dissociation rate constant of the radioligand was similar whether the dissociation was induced by an agonist or an antagonist. Competition studies carried out with agonists and antagonists also suggested the presence of a homogeneous population of [3H]ICS 205-930 recognition sites. Competition curves were best fit for a 1 site model. [3H]ICS 205-930 binding sites displayed the pharmacological profile of a 5-HT3 receptor. The interactions of agonists and antagonists with [3H]ICS 205-930 recognition sites were apparently competitive in nature, as demonstrated in kinetic and equilibrium experiments. In saturation experiments carried out with [3H]ICS 205-930 in the presence and the absence of unlabelled agonists and antagonists, apparent Bmax values were not reduced whereas apparent Kd values were increased in the presence of competing ligands. There was a good agreement between apparent pKB values calculated for the competing ligands in saturation experiments and pKd values calculated from competition experiments. The present data demonstrate that [3H]ICS 205-930 labels a homogeneous population of sites at which agonists and antagonists interact competitively.
[3H]ICS 205 - 930标记了从小鼠神经母细胞瘤N1E - 115细胞制备的膜中的5 - HT3识别位点。结合是快速、可逆、可饱和的,并且对明显均一的位点群体具有立体选择性。动力学研究表明,激动剂和拮抗剂使[3H]ICS 205 - 930从其识别位点发生单相解离反应。无论解离是由激动剂还是拮抗剂诱导,放射性配体的解离速率常数相似。用激动剂和拮抗剂进行的竞争研究也表明存在均一的[3H]ICS 205 - 930识别位点群体。竞争曲线最适合1位点模型。[3H]ICS 205 - 930结合位点表现出5 - HT3受体的药理学特征。如动力学和平衡实验所示,激动剂和拮抗剂与[3H]ICS 205 - 930识别位点的相互作用本质上明显是竞争性的。在用[3H]ICS 205 - 930进行的饱和实验中,在有无未标记激动剂和拮抗剂的情况下,表观Bmax值未降低,而在存在竞争配体时表观Kd值增加。饱和实验中为竞争配体计算的表观pKB值与竞争实验计算的pKd值之间有很好的一致性。目前的数据表明,[3H]ICS 205 - 930标记了一个均一的位点群体,激动剂和拮抗剂在该位点上进行竞争性相互作用。